McCormick & Company, Incorporated (NYSE:MKC) Given New $75.00 Price Target at BNP Paribas Exane

McCormick & Company, Incorporated (NYSE:MKC) had its price objective reduced by BNP Paribas Exane from $83.00 to $75.00 in a report released on Wednesday morning,Benzinga reports. BNP Paribas Exane currently has an outperform rating on the stock.

Other equities research analysts have also issued reports about the company. Deutsche Bank Aktiengesellschaft lowered their price objective on McCormick & Company, Incorporated from $70.00 to $59.00 and set a “buy” rating for the company in a research note on Monday. TD Cowen decreased their price target on McCormick & Company, Incorporated from $75.00 to $64.00 and set a “buy” rating on the stock in a report on Wednesday, March 25th. Sanford C. Bernstein lowered their price target on McCormick & Company, Incorporated from $85.00 to $77.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. JPMorgan Chase & Co. dropped their price objective on shares of McCormick & Company, Incorporated from $78.00 to $67.00 and set an “overweight” rating for the company in a research note on Wednesday, March 25th. Finally, UBS Group cut their price objective on shares of McCormick & Company, Incorporated from $67.00 to $59.00 and set a “neutral” rating on the stock in a research report on Friday, March 20th. Six investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, McCormick & Company, Incorporated presently has an average rating of “Hold” and a consensus target price of $64.27.

McCormick & Company, Incorporated Stock Down 4.5%

Shares of NYSE MKC opened at $48.18 on Wednesday. The firm’s 50-day moving average price is $62.65 and its 200-day moving average price is $65.15. The company has a current ratio of 0.76, a quick ratio of 0.28 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $12.93 billion, a price-to-earnings ratio of 7.90, a P/E/G ratio of 2.95 and a beta of 0.71. McCormick & Company, Incorporated has a 12-month low of $48.05 and a 12-month high of $82.90.

McCormick & Company, Incorporated (NYSE:MKC) last released its quarterly earnings results on Tuesday, March 31st. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.61 by $0.05. McCormick & Company, Incorporated had a return on equity of 13.29% and a net margin of 23.12%.The company had revenue of $1.87 billion during the quarter, compared to analyst estimates of $1.79 billion. During the same quarter last year, the business posted $0.60 earnings per share. The firm’s revenue was up 16.7% on a year-over-year basis. On average, equities research analysts anticipate that McCormick & Company, Incorporated will post 3.07 EPS for the current fiscal year.

Insider Activity at McCormick & Company, Incorporated

In other McCormick & Company, Incorporated news, Director Jacques Tapiero sold 5,000 shares of the company’s stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $67.09, for a total value of $335,450.00. Following the transaction, the director directly owned 31,596 shares in the company, valued at $2,119,775.64. This represents a 13.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Lawrence Erik Kurzius sold 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $71.63, for a total transaction of $3,581,500.00. Following the transaction, the insider directly owned 296,992 shares in the company, valued at approximately $21,273,536.96. This trade represents a 14.41% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 115,000 shares of company stock worth $7,947,300 in the last 90 days. 10.60% of the stock is owned by corporate insiders.

Institutional Trading of McCormick & Company, Incorporated

Several institutional investors and hedge funds have recently modified their holdings of the stock. Elevation Point Wealth Partners LLC bought a new position in McCormick & Company, Incorporated in the second quarter worth approximately $27,000. Heartwood Wealth Advisors LLC bought a new stake in McCormick & Company, Incorporated during the 3rd quarter valued at $28,000. GoalVest Advisory LLC purchased a new stake in shares of McCormick & Company, Incorporated in the 4th quarter worth $28,000. Deseret Mutual Benefit Administrators lifted its holdings in shares of McCormick & Company, Incorporated by 67.8% in the 4th quarter. Deseret Mutual Benefit Administrators now owns 406 shares of the company’s stock worth $28,000 after buying an additional 164 shares during the period. Finally, Motiv8 Investments LLC bought a new position in shares of McCormick & Company, Incorporated during the 4th quarter worth $28,000. Institutional investors own 79.74% of the company’s stock.

Key McCormick & Company, Incorporated News

Here are the key news stories impacting McCormick & Company, Incorporated this week:

• Positive Sentiment: Q1 beat and reaffirmed outlook — McCormick reported better-than-expected Q1 results (EPS $0.66 vs. $0.61 consensus) and revenue +16.7% Y/Y, and reiterated its 2026 outlook, which supports near-term fundamentals. Q1 Results
• Positive Sentiment: Strategic upside from Unilever tie-up — management says the deal will create a ~US$65B flavor/foods company with ~$600M run-rate synergies and accretion potential, a clear long-term growth/doubling revenue thesis if the transaction closes. Deal Announcement
• Positive Sentiment: Some analysts still constructive despite cuts — a number of firms kept Buy/Overweight stances even while lowering targets (e.g., Jefferies, JPMorgan), indicating analysts see value once merger execution/risks are clarified. Jefferies PT Note JPMorgan PT Note
• Neutral Sentiment: Elevated trading & options flow — unusually high volume and a spike in call option activity signal both heavy repositioning and active speculation; this increases short-term volatility but is not a directional fundamental read.
• Neutral Sentiment: Value/deep-discount narrative — some coverage points to MKC trading at deep-value multiples versus history, which could attract long-term income investors if uncertainty subsides.
• Negative Sentiment: Multiple price-target cuts and cautious notes — several brokers trimmed targets (Barclays, Stifel, JPMorgan, Jefferies reductions cited) or moved to neutral/hold, pressuring sentiment and limiting near-term buying. Stifel PT Cut Barclays/JPMorgan Notes
• Negative Sentiment: Shareholder litigation and fairness probes — multiple law firms have launched investigations into whether the Unilever transaction is fair to McCormick shareholders, adding legal/PR risk and potential distraction. KSF Investigation Ademi Alert
• Negative Sentiment: Market skepticism on deal structure and dilution — coverage notes concerns about the cash-and-equity mix, dilution, execution risk and regulatory hurdles; that skepticism has driven near-term selling and a move toward 52‑week lows. Deal Critique

McCormick & Company, Incorporated Company Profile

McCormick & Company, Incorporated (NYSE: MKC) is a global leader in spices, seasonings and flavor solutions. Headquartered in Hunt Valley, Maryland, the company traces its origins to the late 19th century and has grown into a major manufacturer and marketer of branded and private‑label flavor products for consumer, industrial and foodservice markets.

McCormick’s product portfolio includes pure spices and herbs, blended seasonings, marinades, rubs, sauces, extracts and specialty flavorings, along with ingredient systems and custom flavor development for manufacturers and foodservice operators.